A starburst organic sensitizer (see picture) has been designed and synthesized, which shows extremely high overall conversion efficiencies of 10.03% in liquid DSSCs and 8.05% in quasi-solid-state DSSCs.
No takes yet. Share an insight, caveat, or question.
Tan et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: